Dilip Sundaram - Corporate Keynote
PathAI is evolving pathology using machine learning and deep learning techniques to drive faster more accurate diagnosis of disease.
Trond Undheim, PhD, Program Director, MIT Startup Exchange in collaboration with Anne Deconinck, PhD, Executive Director, MIT Koch Institute for Integrative Cancer Research
Panel moderator: Marcus Dahllof, Program Director, MIT Startup Exchange Panelists: Caleb Harper, Director, OpenAg, MIT Media Lab Dilip Sundaram, President, Corporate, Mahindra Group - Americas Jan Schnorr, CEO, C2Sense Alan Kriz, Strategic Alliance Manager, Crop Science, Bayer Tejal Mody, Managing Director, Rabobank
Jan Schnorr, CEO, C2Sense
Rana el Kaliouby, CEO & Cofounder, Affectiva
Sertac Karaman, Cofounder, Optimus Ride
Trond Undheim, PhD, Program Director, MIT Startup Exchange; Paula Hammond, PhD, David H. Koch Professor in Engineering and Department Head, Chemical Engineering, MIT; Laura Indolfi, PhD, CEO of PanTher Therapeutics; Peter Sandor, VP, Head of Oncology Marketing Strategy, Astellas.
Introduced by Marcus Dahllof, Associate Program Director, MIT Startup Exchange; Cliff Reid, PhD, CEO, Travera; Todd Gierahn, PhD, Cofounder, Honeycomb; Laura Indolfi, PhD, CEO & Cofounder, PanTher Therapeutics; Ulrik Nielsen, PhD, CEO & Cofounder, Torque; Jason Norris, Cofounder, Elektrofi; Patrick Stern, PhD, CEO & Founder, Sextant; Carlos Castro-Gonzalez, PhD, CEO & Cofounder, Leuko Labs; and Alec Nielsen, PhD, Cofounder, Asimov.